9am.health Seed

Funding π°
Total $3.7M
Last round π September 16, 2021.
Select investors Founders Fund, Define Ventures, Speedinvest, iSeed Ventures
Key people π§βπ€βπ§
- Anton Kittelberger - Co-CEO
- Frank Westermann - Co-CEO
- Paul Geevarghese - CMO
- Bernhard Schandl - CTO
Highlights β
- Huge addressable market. Diabetes is one of the costliest, most debilitating chronic diseases in the United States, totaling more than $327 billion annually in the U.S. alone. Type 2 diabetes accounts for approximately 90 to 95 percent of the 34 million+ diabetes cases in the U.S., and an additional 88 million American adults (approximately one in three) have prediabetes. π
- Straightforward business model that involves a subscription, which is good for the cash flow.
- 9am.health aims to make access to care a non-issue - rather than having patients waiting for weeks to get an appointment, the company sends them a kit with tests to their home, and then they send it back.
- Proven team with inside knowledge of the diabetes management market - they have previously started the MySugr app and sold it to Roche for $100 million in 2017.
Last update: October 3, 2021
Disclaimer: We can not guarantee that the information on this page is 100% correct. more